PERSONAL P ROT ECT ION EQUI PMENT
an intermediate between the 121˚C / 250˚F steam sterilisation and the 65˚C / 150˚F dry heat disinfection approach, in terms of microbicidal efficacy as well as expected material compatibility.
Implementation as backup option in Austria and Germany: The 105˚C moist heat disinfection method was implemented in standard medical steam sterilisers in some hospital sites in Austria and Germany as an option for the future. Currently, those sites are still preferring to decontaminate suitable FFP2 masks in 105˚C / 221˚F sterilisation programs because this method is currently preferred by the responsible Austrian ministry. However, testing is continued and, if it turns out that the 105˚C / 221˚F program has clear advantages in terms of material compatibility, it can be expected that the health authorities will give a green light for the broader application of this program for FFP2 masks or other items.
Conclusion In this paper, the authors have described a number of contingency reprocessing methods for single-use or reusable personal protective equipment (PPE). The paper outlines their legal and technical rationale as a measure of last resort, during the
IPS and CSC position on re-use of PPE
The Infection Prevention Society (IPS) and Central Sterilising Club (CSC) have issued a joint paper on “Strategies for managing acute shortages of personal protective equipment”.
This document has been developed to guide infection prevention and control teams in light of the current acute shortages of personal protective equipment (PPE) due to the COVID-19 epidemic. IPS and CSC agree that “Re-use and reprocessing of PPE must be a last-resort temporary measure that is implemented for a limited time period to enable stocks to be replenished.”
This paper provides infection prevention and control teams with a checklist of actions and practical strategies that can be
current supply shortage due to the global COVID-19 pandemic. The document is updated regularly when new information is available. The latest version can be requested by email.
The authors encourage any interested stakeholder to get into contact with Belimed’s Scientific Affairs department,
used to inform local risk assessments to manage shortages of PPE. IPS president, Pat Cattini, said: “We have undertaken this piece of work to give practical guidance to our members, many of whom are facing critical shortages of PPE for managing COVID-19 patients. This advice has been prepared to help them navigate safe and effective strategies to manage the issues they face and provide healthcare workers with the protection they need. IPS members are at the forefront of trying to ensure healthcare workers have the equipment they need and that they know how to use it correctly.” To read the guidelines in full see:
https://bit.ly/IPSCSCPPE
to improve this document by expanding the information, removing discrepancies or adding experiences of contingency reprocessing methods or additional examples that would be worth sharing. Email:
scientific_affairs@belimed.com CSJ
*References available on request.
Safe Swab Sample Collection & Packaging for UN3373 Transport
Full Range of Swabs ■ With or without preservation/transport medium
■ Bulk or individually packed Expertise in UN3373 Packaging Regulations ■ Complete kits for compliant sample transport
■ Absorbent sheets, biohazard bags, 95kPa pouches, outer boxes, labels, seals etc.
Tel: 023 8048 3000 | Web:
www.un3373.co.uk OCTOBER 2020 CSJ_September_Coronavirus_Infection Prevention digital magazine
2020.indd 1 24/08/2020 16:30:12
WWW.CLINICALSERVICESJOURNAL.COM l 71
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92
